References
- Cao J, Yang X, Li WT, et al (2014). Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade. Asian Pac J Cancer Prev, 15, 9967-72. https://doi.org/10.7314/APJCP.2014.15.22.9967
- Ciccarone F, Valentini E, Bacalini MG, et al (2014). Poly(ADPribosyl) ation is involved in the epigenetic control of TET1 gene transcription. Oncotarget.
- Gan H, Wen L, Liao S, et al (2013). Dynamics of 5-hydroxymethylcytosine during mouse spermatogenesis. Nat Commun, 4, 1995.
- Gong C, Qu S, Lv XB, et al (2014). BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. Nat Commun, 5, 5406. https://doi.org/10.1038/ncomms6406
- He YF, Li BZ, Li Z, et al (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-7. https://doi.org/10.1126/science.1210944
- Hong R, Shen MH, Xie XH, et al (2012). Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid. Asian Pac J Cancer Prev, 13, 1877-80. https://doi.org/10.7314/APJCP.2012.13.5.1877
- Hsu CH, Peng KL, Kang ML, et al (2012). TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep, 2, 568-79. https://doi.org/10.1016/j.celrep.2012.08.030
- Kudo Y, Tateishi K, Yamamoto K, et al (2012). Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci, 103, 670-6. https://doi.org/10.1111/j.1349-7006.2012.02213.x
- Li J, Qiu DM, Chen SH, et al (2014). Suppression of human breast cancer cell metastasis by coptisine in vitro. Asian Pac J Cancer Prev, 15, 5747-51. https://doi.org/10.7314/APJCP.2014.15.14.5747
- Lian CG, Xu Y, Ceol C, et al (2012). Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell, 150, 1135-46. https://doi.org/10.1016/j.cell.2012.07.033
- Liu Y, Li H, Feng J, et al (2013). Lin28 induces epithelial-tomesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. PLoS One, 8, 83083. https://doi.org/10.1371/journal.pone.0083083
- Lv XB, Jiao Y, Qing Y, et al (2011). miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer, 30, 821-30. https://doi.org/10.5732/cjc.011.10289
- Mariani CJ, Vasanthakumar A, Madzo J, et al (2014). TET1- mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Rep, 7, 1343-52. https://doi.org/10.1016/j.celrep.2014.04.040
- Mercher T, Quivoron C, Couronne L, et al (2012). TET2, a tumor suppressor in hematological disorders. Biochim Biophys Acta, 1825, 173-7.
- Pastor WA, Aravind L, Rao A (2013). TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol, 14, 341-56. https://doi.org/10.1038/nrm3589
- Sun M, Song CX, Huang H, et al (2013). HMGA2/TET1/ HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci U S A, 110, 9920-5. https://doi.org/10.1073/pnas.1305172110
- Tahiliani M, Koh KP, Shen Y, et al (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-5. https://doi.org/10.1126/science.1170116
- Truong PK, Lao TD, Doan TP, et al (2014). BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population. Asian Pac J Cancer Prev, 15, 9607-10. https://doi.org/10.7314/APJCP.2014.15.22.9607
- Wu H, Zhang Y (2014). Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell, 156, 45-68. https://doi.org/10.1016/j.cell.2013.12.019
- Xu Y, Gao XD, Lee JH, et al (2014). Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev, 28, 1191-203. https://doi.org/10.1101/gad.241968.114
- Yang H, Liu Y, Bai F, et al (2013). Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene, 32, 663-9. https://doi.org/10.1038/onc.2012.67
Cited by
- Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis vol.35, pp.5, 2016, https://doi.org/10.3892/or.2016.4647
- The application of genome-wide 5-hydroxymethylcytosine studies in cancer research vol.9, pp.1, 2017, https://doi.org/10.2217/epi-2016-0122
- TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells vol.10, pp.1, 2018, https://doi.org/10.1186/s13148-018-0535-7